4 1 v74539ae4.txt FORM 4 1 ------ UNITED STATES SECURITIES AND EXCHANGE COMMISSION ------------------------------ FORM 4 WASHINGTON, D.C. 20549 OMB APPROVAL ------ ------------------------------ STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OMB NUMBER: 3235-0287 [ ] CHECK THIS BOX IF NO EXPIRES: SEPTEMBER 30, 1998 LONGER SUBJECT TO Filed pursuant to Section 16(a) of the Securities ESTIMATED AVERAGE BURDEN SECTION 16. FORM 4 Exchange Act of 1934, Section 17(a) of the HOURS PER RESPONSE.........0.5 OR FORM 5 OBLIGATIONS Public Utility Holding Company Act of 1935 ------------------------------ MAY CONTINUE. SEE or Section 30(f) of the Investment Company INSTRUCTION 1(b). Act of 1940 (Print or Type Responses) ------------------------------------------------------------------------------------------------------------------------------------ 1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol 6. Relationship of Reporting Person(s) WILKINS J. STEPHEN CARDIOGENESIS CORPORATION/CGCP (NASDAQ) to Issuer (Check all applicable) -------------------------------------------- ---------------------------------------------- Director 10% Owner (Last) (First) (Middle) 3. IRS or Social Security 4. Statement for ---- --- C/O CARDIOGENESIS CORPORATION Number of Reporting Month/Year X Officer (give Other (specify 26632 TOWNE CENTER DRIVE, SUITE 320 Person (Voluntary) JULY 2001 ---- title below) --- below) -------------------------------------------- ------------------- (Street) 5. If Amendment, Vice President and Chief FOOTHILL RANCH, CA 92610 Date of Original Financial Officer -------------------------------------------- (Month/Year) ------------------------------------ (City) (State) (Zip) 7. Individual or Joint/Group Reporting ------------------- (Check Applicable Line) Form filed by One ---- Reporting Person Form filed by More than ---- One Reporting Person ------------------------------------------------------------------------------------------------------------------------------------ TABLE I -- NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED ------------------------------------------------------------------------------------------------------------------------------------ 1. Title of Security 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Ownership 7. Nature of (Instr. 3) action action or Disposed of (D) Securities Form Indirect Date Code (Instr. 3, 4 and 5) Beneficially Direct Beneficial (Instr. 8) Owned at (D) or Ownership (Month/ End of Month Indirect (Instr. 4) Day/ --------------------------------------- (Instr. 3 and 4) (I) Year) Code V Amount (A) or Price (Instr. 4) (D) ------------------------------------------------------------------------------------------------------------------------------------ COMMON STOCK 7/31/01 P 3,200 A $0.94 D ------------------------------------------------------------------------------------------------------------------------------------ COMMON STOCK 7/31/01 P 500 A $0.93 3,700 D ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. (Over) *If the form is filed by more than one reporting person, see Instruction 4(b)(v). SEC 2270 (7-96)

WILKINS J STEPHEN 4